Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)

R Soffietti, U Abacioglu, B Baumert, SE Combs… - Neuro …, 2017 - academic.oup.com
The management of patients with brain metastases has become a major issue due to the
increasing frequency and complexity of the diagnostic and therapeutic approaches. In 2014 …

Treatment of brain metastases

X Lin, LM DeAngelis - Journal of clinical oncology, 2015 - ascopubs.org
Brain metastases (BMs) occur in 10% to 20% of adult patients with cancer, and with
increased surveillance and improved systemic control, the incidence is likely to grow …

Radiation therapy for brain metastases: an ASTRO clinical practice guideline

V Gondi, G Bauman, L Bradfield, SH Burri… - Practical radiation …, 2022 - Elsevier
Purpose This guideline provides updated evidence-based recommendations addressing
recent developments in the management of patients with brain metastases, including …

Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial

PD Brown, K Jaeckle, KV Ballman, E Farace… - Jama, 2016 - jamanetwork.com
Importance Whole brain radiotherapy (WBRT) significantly improves tumor control in the
brain after stereotactic radiosurgery (SRS), yet because of its association with cognitive …

The evolving landscape of brain metastasis

M Valiente, MS Ahluwalia, A Boire, PK Brastianos… - Trends in cancer, 2018 - cell.com
Metastasis, involving the spread of systemic cancer to the brain, results in neurologic
disability and death. Current treatments are largely palliative in nature; improved therapeutic …

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial

EL Chang, JS Wefel, KR Hess, PK Allen… - The lancet …, 2009 - thelancet.com
Background It is unclear whether the benefit of adding whole-brain radiation therapy
(WBRT) to stereotactic radiosurgery (SRS) for the control of brain-tumours outweighs the …

A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three …

R Soffietti, M Kocher, UM Abacioglu, S Villa… - Journal of clinical …, 2013 - ascopubs.org
Purpose This phase III trial compared adjuvant whole-brain radiotherapy (WBRT) with
observation after either surgery or radiosurgery of a limited number of brain metastases in …

[HTML][HTML] Radiotherapeutic and surgical management for newly diagnosed brain metastasis (es): An American Society for Radiation Oncology evidence-based …

MN Tsao, D Rades, A Wirth, SS Lo… - Practical radiation …, 2012 - Elsevier
Purpose To systematically review the evidence for the radiotherapeutic and surgical
management of patients newly diagnosed with intraparenchymal brain metastases. Methods …

Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 …

PW Sperduto, ST Chao, PK Sneed, X Luo, J Suh… - International Journal of …, 2010 - Elsevier
PURPOSE: Controversy endures regarding the optimal treatment of patients with brain
metastases (BMs). Debate persists, despite many randomized trials, perhaps because BM …

Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

V Subbiah, JF Gainor, GR Oxnard, DSW Tan… - Clinical Cancer …, 2021 - AACR
Purpose: We report the intracranial efficacy of selpercatinib, a highly potent and selective
RET inhibitor, approved in the United States for RET fusion-positive non–small cell lung …